BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9840114)

  • 1. Mediators of inflammation: production and implication in inflammatory bowel disease.
    Kolios G; Petoumenos C; Nakos A
    Hepatogastroenterology; 1998; 45(23):1601-9. PubMed ID: 9840114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.
    Powrie F; Uhlig H
    Novartis Found Symp; 2004; 263():164-74; discussion 174-8, 211-8. PubMed ID: 15669641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms.
    Dignass AU; Baumgart DC; Sturm A
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():9-17. PubMed ID: 15352888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
    Fiocchi C
    Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
    Sartor RB
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of mucosal inflammation: implications for therapy.
    van Dullemen H; Meenan J; Stronkhorst A; Tytgat GN; van Deventer SJ
    Scand J Gastroenterol Suppl; 1997; 223():92-8. PubMed ID: 9200313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nitric oxide and inflammatory bowel disease].
    García-González MA; Peña AS
    Rev Esp Enferm Dig; 1998 Dec; 90(12):870-6. PubMed ID: 9973849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.
    Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M
    Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.
    Shkoda A; Ruiz PA; Daniel H; Kim SC; Rogler G; Sartor RB; Haller D
    Gastroenterology; 2007 Jan; 132(1):190-207. PubMed ID: 17241871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
    Brun P; Mastrotto C; Beggiao E; Stefani A; Barzon L; Sturniolo GC; Palù G; Castagliuolo I
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G621-9. PubMed ID: 15764810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of disturbed electrolyte transport in intestinal inflammation.
    Seidler U; Lenzen H; Cinar A; Tessema T; Bleich A; Riederer B
    Ann N Y Acad Sci; 2006 Aug; 1072():262-75. PubMed ID: 17057206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistologic changes of the intestinal mucosa in chronic inflammatory bowel diseases].
    Arató A
    Orv Hetil; 2002 Dec; 143(49):2723-30. PubMed ID: 12587540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.